KPC Pharmaceuticals, Inc. (600422.SS) SHH

Currency In CNY

AD

Valuation

Market Cap9.55B
Enterprise Value10.43B
P/E Ratio-30.37
PEG Ratio0.23
Price/Sales Ratio1.33
Price/Book Ratio1.33
Enterprise/Revenue1.58
Enterprise/EBITDA-101.67

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.04
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.04

Income Statement

Revenue6.58B
Revenue/Share6.43
Gross Profit2.53B
EBITDA638.22M
Net Income349.94M
Diluted EPS0.46

Balance Sheet

Total Cash1.71B
Total Cash/Share2.26
Total Debt2.09B
Total Debt/Equity0.43
Current Ratio1.95
Book Value Per Share8.82

Price History

52-Week Change-40.65
52-Week High14.98
52-Week Low7.45
Moving Average 50 Days8.64
Moving Average 200 Days10.85

Statistics

Average Volume12.06M
Shares Outstanding756.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield2.11
Payout Ratio-1.9
Last Split Factor2:1
Last Split DateMay 09, 2016
AD